228 related articles for article (PubMed ID: 21285534)
1. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
2. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A outbreaks: the effect of a mass vaccination programme.
Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
5. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme.
Godoy P; Carmona G; Manzanares S; Jane M; Borràs E; Camps N; Álvarez J; Barrabeig I; Sala MR; Rius C; Minguell S; Carol M; Ferras J; Domínguez A;
J Viral Hepat; 2018 Sep; 25(9):1001-1007. PubMed ID: 29603832
[TBL] [Abstract][Full Text] [Related]
6. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
Domínguez A; Oviedo M; Carmona G; Batalla J; Bruguera M; Salleras L; Plasència A
Vaccine; 2008 Mar; 26(14):1737-41. PubMed ID: 18325642
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
Borràs E; Urbiztondo L; Carmona G; Jané M; Barrabeig I; Rosa Sala M; Jorgina Balañà JP; Company M; Parrón I; Godoy P; Rius C; Soldevila N; Cabezas C; Domínguez À;
Vaccine; 2019 Feb; 37(9):1137-1141. PubMed ID: 30709729
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a mass hepatitis A vaccination program in preadolescents.
Domínguez A; Salleras L; Carmona G; Batalla J
Vaccine; 2003 Jan; 21(7-8):698-701. PubMed ID: 12531343
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.
Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A;
Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.
Crespo I; Broner S; Soldevila N; Martínez A; Godoy P; Sala-Farré MR; Company M; Rius C; Domínguez A; Group Of Catalonia TP
Hum Vaccin Immunother; 2015; 11(1):231-5. PubMed ID: 25483541
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
14. Incidence of hepatitis A in the United States in the era of vaccination.
Wasley A; Samandari T; Bell BP
JAMA; 2005 Jul; 294(2):194-201. PubMed ID: 16014593
[TBL] [Abstract][Full Text] [Related]
15. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers' Vaccination: A Population-Based Study in Israel.
Bassal R; Weil M; Cohen D; Sofer D; Mendelson E; Shohat T
Pediatr Infect Dis J; 2017 Oct; 36(10):e248-e251. PubMed ID: 28498301
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatitis A in Israel following universal immunization of toddlers.
Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
[TBL] [Abstract][Full Text] [Related]
19. [Study of a population outbreak of hepatitis A. Effectiveness of vaccination as a control measure].
Díaz Villaescusa MJ; Almar Marqués E; Gómez Martínez A; Mateos Ramos A; Segura Cebollada P; de la Cruz de Julián I; Navarro Honrubia C; Ramírez Córcoles C
Gac Sanit; 2010; 24(4):329-33. PubMed ID: 20483510
[TBL] [Abstract][Full Text] [Related]
20. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
